In palliative care for dyspnea in end-stage heart failure, which pharmacologic option is commonly used for symptom relief?

• A. Opioid therapy
• B. High-dose digitoxin
• C. Long-acting nitrates for relief
• D. Calcium channel blockers

Answer: (A)

Opioid therapy is used for dyspnea relief in advanced heart failure because it directly reduces the sensation of air hunger and the anxiety that often accompanies severe breathlessness. By blunting the central perception of dyspnea and lowering the ventilatory drive to CO2, low-dose opioids like morphine or fentanyl can markedly improve comfort even when the underlying heart failure remains end-stage. They may also cause mild venodilation, which can reduce preload and pulmonary congestion, further easing breathing. In palliative care, the goal is symptom relief, so opioids are the pharmacologic option most commonly employed for this purpose.

High-dose digitalis is not used for dyspnea palliation and carries toxicity risks. Nitrates and calcium channel blockers target preload or blood pressure and are not standard for relieving dyspnea in end-stage heart failure; they can worsen symptoms or be ineffective in this context.